id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1461-0003,FDA,FDA-2014-D-1461,"Rare Pediatric Disease Priority Review Vouchers; Extension of Comment
Period",Notice,Extension of Comment Period,2014-12-24T05:00:00Z,2014,12,2014-12-24T05:00:00Z,2015-02-17T04:59:59Z,2015-03-25T02:02:24Z,2014-30154,0,0,09000064819914d2
FDA-2014-D-1461-0002,FDA,FDA-2014-D-1461,"Rare Pediatric Disease Priority Review Vouchers, Draft Guidance for Industry",Other,Guidance,2014-11-18T05:00:00Z,2014,11,2014-11-18T05:00:00Z,2015-02-17T04:59:59Z,2019-10-23T14:42:29Z,,0,0,09000064819365ff
FDA-2014-D-1461-0001,FDA,FDA-2014-D-1461,"Rare Pediatric Disease Priority Review Vouchers, Draft Guidance for Industry;
Availability",Notice,Notice of Availability,2014-11-17T05:00:00Z,2014,11,2014-11-17T05:00:00Z,2014-12-25T04:59:59Z,2014-12-24T19:51:24Z,2014-27022,0,0,0900006481932cf7